Vident Advisory’s Elevance Health ELV Stock Holding History

Vident Advisory’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$34.4M	Buy	117,473 +25,703	+28%	+$8.45M	0.29%	66
2025 Q4	$32.2M	Buy	91,770 +5,364	+6%	+$1.81M	0.29%	73
2025 Q3	$27.9M	Buy	86,406 +22,178	+35%	+$6.9M	0.27%	83
2025 Q2	$25M	Buy	64,228 +14,326	+29%	+$5.76M	0.28%	84
2025 Q1	$21.7M	Buy	49,902 +6,448	+15%	+$2.59M	0.32%	70
2024 Q4	$16M	Buy	43,454 +33,473	+335%	+$14M	0.28%	76
2024 Q3	$5.19M	Buy	9,981 +7,357	+280%	+$3.93M	0.13%	150
2024 Q2	$1.42M	Sell	2,624 -58,463	-96%	-$30.9M	0.04%	475
2024 Q1	$31.7M	Buy	61,087 +10,573	+21%	+$5.26M	0.66%	22
2023 Q4	$23.8M	Buy	50,514 +7,417	+17%	+$3.43M	0.6%	21
2023 Q3	$18.8M	Buy	+43,097	New	+$19.5M	0.58%	26

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Vident Advisory's ELV Position: Q1 2026 in Review

Vident Advisory increased its Elevance Health (ELV) stake by 28% in Q1 2026, buying an estimated $8.45M and bringing the position to 117,473 shares worth $34.4M. The position accounts for 0.29% of the portfolio, ranked #66.

Vident Advisory first reported a position in ELV in Q3 2023 and has held it in 11 quarters since. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Vident Advisory held 117,473 shares of Elevance Health worth $34.4M as of Q1 2026.
Vident Advisory bought 25,703 Elevance Health shares in Q1 2026, an estimated $8.45M.
Elevance Health made up 0.29% of Vident Advisory's portfolio in Q1 2026, its #66 holding.
Vident Advisory first reported a position in Elevance Health in Q3 2023 and has held it in 11 quarters since.
1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.